Zdrowie i gospodarka · 14/04/2022

FDA Releases Draft Guidance on Waiver Requests for pH Adjusters in Generic Drug Products

The FDA has announced the availability of a draft guidance to help generic drug manufacturers seeking approval for drugs with pH adjusters that differ from the reference listed drug, providing recommendations on the type of information to provide and the timing for submitting waiver requests.